Eloxx Pharmaceuticals (ELOX) Misses Q2 EPS by 2c

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

You May Also Be Interested In

• Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'